IL22 and cancer: It is also shown that the increased intratumoral IL-22-producing CD4+ T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival. 86,87  It is demonstrated that IL-22 expression and signaling is dysregulated in patients affected by many common cancers including skin, liver, gut and lung.